Effect of Alemtuzumab on serum neurofilament light chain levels in RRMS patients with or without highly active disease: comparison with SC IFNB-1a and 7-year assessment (CARE-MS I)
MULTIPLE SCLEROSIS JOURNAL（2019）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要